Related Experiment Video

Updated: Oct 4, 2026

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
06:03

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Published on: September 20, 2024

Host immune reactivity and antifungal chemotherapy: the power of being together

L Romani1

  • 1Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy. lromani@unipg.it

Journal of Chemotherapy (Florence, Italy)
|October 9, 2001
PubMed

Insights

Understanding fungal infection immunoregulation offers new therapeutic strategies. Manipulating T helper cells and cytokines can improve antifungal drug efficacy, especially in immunocompromised patients.

Area of Science:

  • Immunology
  • Mycology
  • Infectious Diseases

Background:

  • Fungal infections pose significant therapeutic challenges, particularly in immunocompromised individuals.
  • Difficult diagnosis, emerging pathogens, and shifting causative organisms impede antifungal therapy effectiveness.
  • Understanding immune regulation is crucial for novel therapeutic interventions.

Purpose of the Study:

  • To explore the role of immunoregulation in fungal infections.
  • To identify potential therapeutic targets for enhancing antifungal treatments.
  • To investigate the manipulation of immune responses for improved patient outcomes.

Main Methods:

  • Review of current literature on T helper cells and cytokines in fungal immunity.
  • Analysis of preclinical and experimental studies on immune modulation.
  • Exploration of cytokine-based therapies and their combination with antifungals.

Main Results:

  • T helper cells and cytokines are key in coordinating immune responses to fungi.
  • Manipulating these immune components offers opportunities to alter infection outcomes.
  • Cytokine-based strategies show potential in overcoming host immune defects.

Conclusions:

  • Knowledge of immunoregulation provides novel therapeutic avenues for fungal infections.
  • Targeting T helper cells and cytokines can enhance antifungal drug efficacy.
  • Translating preclinical findings into clinical strategies remains a key challenge for effective fungal infection treatment.

More Related Videos

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...